EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Evaluation of Modified Vaccinia Ankara as a Surrogate Virus for Disinfectant Efficacy Testing Against AIV, FMDV, and ASFV

Sok Song iD, Su-Jeong Kim, Kyu-Sik Shin, So-Hee Park, Yong Yi Joo, Bokhee Han, Cho-Yeon Lee, Gong-Woo Park, Hyun-Ok Ku, Wooseog Jeong iD, Choi-Kyu Park iD

Viruses · 23.08.2025 · 17 (9) · 1156

DOI: 10.3390/v17091156 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Viruses, online erschienen am 23.08.2025. Verfasst von Sok Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Drugs & Biologics Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Republic of Korea. Hauptthemen laut MEDLINE: Disinfectants, Vaccinia virus, Foot-and-Mouth Disease Virus, African Swine Fever Virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Animal and Plant Quarantine Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surrogate viruses provide a safe and scalable alternative for evaluating disinfectant efficacy when access to high-risk pathogens is restricted. This study evaluated the potential of Modified Vaccinia Ankara (MVA) virus, which can be handled under BSL-1/2 conditions, as a surrogate for avian influenza virus (AIV), foot-and-mouth disease virus (FMDV), and African swine fever virus (ASFV). A total of 64 commercially available disinfectants—classified into four major chemical groups: quaternary ammonium compounds, oxidizing agents, PPMS-based formulations, and organic acids—were tested in suspension assays using a ≥4 log reduction as the efficacy criterion. MVA showed the strongest predictive performance for FMDV (r = 0.671, AUC = 0.83), supporting its use for both binary classification and approximate quantitative prediction. Although its correlation with ASFV was weaker (r = 0.175), the classification performance remained moderate (AUC = 0.78), indicating conditional applicability. While MVA exhibited no meaningful correlation with AIV, its higher chemical resistance meant that disinfectants effective against MVA were consistently effective against AIV. These results support the use of MVA as a conservative exclusion tool for fragile viruses. Overall, the findings demonstrate that MVA can serve as a practical surrogate virus for disinfectant efficacy testing against FMDV, ASFV, and AIV, with application strategies tailored to each virus’s characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DisinfectantsVaccinia virusFoot-and-Mouth Disease VirusAfrican Swine Fever VirusInfluenza A virusAnimals

Stichwörter der Autor:innen

AIVASFVFMDVMVAsurrogate virusvirucidal efficacy testing

Substanzen

Disinfectants

Autor:innen und Institutionen

  • Veterinary Drugs & Biologics Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Republic of Korea.
  • Institute for Veterinary Biomedical Science, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.

ORCID-Profile: Sok Song, Wooseog Jeong, Choi-Kyu Park

Förderung

  • Animal and Plant Quarantine Agency

Zitieren

APA

Song, S., Kim, S. J., Shin, K. S., Park, S. H., Joo, Y. Y., Han, B., Lee, C. Y., Park, G. W., Ku, H. O., Jeong, W., & Park, C. K. (2025). Comparative Evaluation of Modified Vaccinia Ankara as a Surrogate Virus for Disinfectant Efficacy Testing Against AIV, FMDV, and ASFV. Viruses, 17(9), 1156. https://doi.org/10.3390/v17091156

Vancouver

Song S, Kim SJ, Shin KS, Park SH, Joo YY, Han B, et al. Comparative Evaluation of Modified Vaccinia Ankara as a Surrogate Virus for Disinfectant Efficacy Testing Against AIV, FMDV, and ASFV. Viruses. 2025;17(9):1156. doi:10.3390/v17091156

BibTeX
@article{Song2025,
  author = {Song, Sok and Kim, Su-Jeong and Shin, Kyu-Sik and Park, So-Hee and Joo, Yong Yi and Han, Bokhee and Lee, Cho-Yeon and Park, Gong-Woo and Ku, Hyun-Ok and Jeong, Wooseog and Park, Choi-Kyu},
  title = {Comparative Evaluation of Modified Vaccinia Ankara as a Surrogate Virus for Disinfectant Efficacy Testing Against AIV, FMDV, and ASFV},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {9},
  pages = {1156},
  doi = {10.3390/v17091156}
}
Kostenlos starten →